Literature DB >> 1431949

Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study.

A Feinstein1, L D Kartsounis, D H Miller, B D Youl, M A Ron.   

Abstract

There is a dearth of longitudinal studies on psychometric and psychiatric change in multiple sclerosis (MS) particularly on the evolution of these abnormalities early in the disease process. A 4 1/2 year follow up study documenting magnetic resonance imaging (MRI), psychometric, and psychiatric abnormalities was undertaken in a group of 48 patients with clinically isolated lesions--for example, optic neuritis--which are frequently the harbinger of MS. At follow up about half the subjects had developed clinically definite MS, with memory deficits becoming apparent. Deficits in attention documented at initial assessment were present but unchanged in those subjects who still had a clinically isolated lesion status. However, after MS was categorised into a relapsing-remitting or chronic progressive course, patients with a chronic progressive course were found to have significantly deteriorated with regard to auditory attention tasks. T1 relaxation times in apparently normal white matter correlated with certain indices of cognitive impairment. In developing a model to explain the pathogenesis of intellectual and emotional change in MS, the interaction of organic, psychological, and social factors needs to be emphasised.

Entities:  

Mesh:

Year:  1992        PMID: 1431949      PMCID: PMC1015179          DOI: 10.1136/jnnp.55.10.869

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  42 in total

1.  Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging.

Authors:  G P Anzola; L Bevilacqua; S F Cappa; R Capra; L Faglia; E Farina; G Frisoni; C Mariani; M P Pasolini; L A Vignolo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

2.  Neuropsychological test performance as a function of the duration of MS-related symptomatology.

Authors:  R J Ivnik
Journal:  J Clin Psychiatry       Date:  1978-04       Impact factor: 4.384

Review 3.  Affective disorders in multiple sclerosis. Review and recommendations for clinical research.

Authors:  S L Minden; R B Schiffer
Journal:  Arch Neurol       Date:  1990-01

4.  Preserved recall versus impaired recognition. A case study.

Authors:  J Delbecq-Derouesné; M F Beauvois; T Shallice
Journal:  Brain       Date:  1990-08       Impact factor: 13.501

5.  Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test.

Authors:  H E Nelson; A O'Connell
Journal:  Cortex       Date:  1978-06       Impact factor: 4.027

6.  A modified card sorting test sensitive to frontal lobe defects.

Authors:  H E Nelson
Journal:  Cortex       Date:  1976-12       Impact factor: 4.027

7.  Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study.

Authors:  M A Ron; M M Callanan; E K Warrington
Journal:  Psychol Med       Date:  1991-02       Impact factor: 7.723

8.  Cognitive disturbances in patients with relapsing remitting multiple sclerosis.

Authors:  W W Beatty; D E Goodkin; N Monson; P A Beatty
Journal:  Arch Neurol       Date:  1989-10

9.  Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study.

Authors:  M M Callanan; S J Logsdail; M A Ron; E K Warrington
Journal:  Brain       Date:  1989-04       Impact factor: 13.501

10.  Disability and intellectual function in multiple sclerosis patients.

Authors:  G G Marsh
Journal:  J Nerv Ment Dis       Date:  1980-12       Impact factor: 2.254

View more
  26 in total

1.  Computerised volumetric analysis of lesions in multiple sclerosis using new semi-automatic segmentation software.

Authors:  P Dastidar; T Heinonen; T Vahvelainen; I Elovaara; H Eskola
Journal:  Med Biol Eng Comput       Date:  1999-01       Impact factor: 2.602

2.  Multiple sclerosis masquerade.

Authors:  S Hunyi; G Nanayakkara
Journal:  Br J Gen Pract       Date:  2001-06       Impact factor: 5.386

3.  Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.

Authors:  Tomas Uher; Jana Blahova-Dusankova; Dana Horakova; Niels Bergsland; Michaela Tyblova; Ralph H B Benedict; Tomas Kalincik; Deepa P Ramasamy; Zdenek Seidl; Jesper Hagermeier; Manuela Vaneckova; Jan Krasensky; Eva Havrdova; Robert Zivadinov
Journal:  J Neurol       Date:  2014-06-22       Impact factor: 4.849

4.  Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.

Authors:  Philip Brenner; Ellenor Mittendorfer-Rutz; Jussi Jokinen; Kristina Alexanderson; Jan Hillert; Petter Tinghög
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-05-11       Impact factor: 4.328

Review 5.  The neuropsychology of multiple sclerosis: contributions of neuroimaging research.

Authors:  H A Wishart; L Flashman; A J Saykin
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

6.  Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.

Authors:  M S A Deloire; E Salort; M Bonnet; Y Arimone; M Boudineau; H Amieva; B Barroso; J-C Ouallet; C Pachai; E Galliaud; K G Petry; V Dousset; C Fabrigoule; B Brochet
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

Review 7.  The link between multiple sclerosis and depression.

Authors:  Anthony Feinstein; Sandra Magalhaes; Jean-Francois Richard; Blair Audet; Craig Moore
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

8.  Cognitive impairment in probable multiple sclerosis.

Authors:  A Achiron; Y Barak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

Review 9.  Exercise and multiple sclerosis.

Authors:  Lesley J White; Rudolph H Dressendorfer
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 10.  Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.

Authors:  Bridget Bagert; Patricia Camplair; Dennis Bourdette
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.